BioCryst (BCRX) Turns its First Profit and Now Wants to Go Shopping for Rare Disease Drugs

Reported by Yahoo Finance · Published 18 Sep 2026, 12:06 AM MYT (1 hr ago)

Summary

Source & full coverage: this summary is aggregated from Yahoo Finance, the original publisher. Read the complete report for full context, data and quotes.

Read the original report at Yahoo Finance →

Most Recent

Lululemon (LULU) Cuts its Outlook Again Just as a New CEO Walks through the Door 34 min ago AMD Leads Chip Stocks Higher Amid Sector Rebound 34 min ago The SEC and CFTC Say They Will Write Crypto Rules Without Congress. What Atkins and Selig Can Actually Do for XRP and Bitcoin. 35 min ago Rackspace’s Nvidia Partnership Sparks Early Rally, But a $2.8 Billion Debt Load Remains 37 min ago CEO Claims Investors Got It Wrong on $30 Billion Shortfall as ON Stock Plummets 9% 41 min ago Meta (META) Overhauls Instagram and Facebook for Teens after its $17 Billion Settlement 41 min ago

EconPulse

Markets. Economy. Malaysia & The World.

Independent economic news aggregation for Malaysia, Asia and global markets, updated throughout the day.

Company

About Us Editorial Standards & Corrections Privacy Policy

Work With Us

Submit a Press Release Partnerships & Advertising Contact Us RSS Feed

Contact

editor@econpulse.my

Editorial & newsroom enquiries answered within 1–2 business days.

BioCryst (BCRX) Turns its First Profit and Now Wants to Go Shopping for Rare Disease Drugs

Summary

More in Markets

Lululemon (LULU) Cuts its Outlook Again Just as a New CEO Walks through the Door

AMD Leads Chip Stocks Higher Amid Sector Rebound

The SEC and CFTC Say They Will Write Crypto Rules Without Congress. What Atkins and Selig Can Actually Do for XRP and Bitcoin.

Rackspace’s Nvidia Partnership Sparks Early Rally, But a $2.8 Billion Debt Load Remains

CEO Claims Investors Got It Wrong on $30 Billion Shortfall as ON Stock Plummets 9%

Meta (META) Overhauls Instagram and Facebook for Teens after its $17 Billion Settlement